26
Mon, Sep
50 New Articles

NKO Partners Advises Dr. Max Group on Acquisition of K-Pharma

NKO Partners Advises Dr. Max Group on Acquisition of K-Pharma

Serbia
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

NKO Partners has advised the Dr. Max Group on another pharmacy chain acquisition in Serbia – that of Belgrade-based K-Pharma.

According to NKO, following the new acquisition, Dr. Max now has more than 190 pharmacies in Serbia.

The Dr. Max Group is a Prague-headquartered pharmacy chain operating in Central and Eastern Europe. The company has over 2,200 pharmacies in six countries, including the Czech Republic, Slovakia, Poland, Romania, Serbia, and Italy. K-Pharma is a Belgrade-based pharmacy chain.

NKO Partners previously advised the Dr. Max Group on its acquisition of the Janja pharmacy chain (as reported by CEE Legal Matters on March 28, 2022) and the Zlatni Lav pharmacies (as reported on January 5, 2022).

The NKO team was led by Partner Djordje Nikolic and Senior Associate Branko Jankovic.

Our Latest Issue